Comparison of drug efficacy between linaclotide and lubiprostone in constipation-predominant irritable bowel syndrome patients
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Linaclotide (Primary) ; Lubiprostone (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 10 Jan 2019 Status changed from recruiting to completed.
- 27 Dec 2018 According to UMIN, the date for data entry closure is 31/03/2019.
- 15 Aug 2018 Status changed from not yet recruiting to recruiting.